Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Efficacy of N-Acetylcysteine in Preventing Those With Mild or Moderate COVID-19 From Progressing to Severe Disease

NCT04419025 is registered in ClinicalTrials.gov with Cambridge Health Alliance as lead sponsor.

NCT NCT04419025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04419025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Efficacy of N-Acetylcysteine in Preventing Those With Mild or Moderate COVID-19 From Progressing to Severe Disease
Lead sponsor
Cambridge Health Alliance
Phase
Phase 2
Overall status
Completed
Start date
September 23, 2020
Completion date
May 14, 2021
Enrollment
165 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid, oxidative stress, sars-associated coronavirus as cause of disease classified elsewhere, sars-cov2